Your browser doesn't support javascript.
loading
Treatment of COVID-19 with pentoxifylline: Could it be a potential adjuvant therapy?
Seirafianpour, Farnoosh; Mozafarpoor, Samaneh; Fattahi, Nima; Sadeghzadeh-Bazargan, Afsaneh; Hanifiha, Melika; Goodarzi, Azadeh.
Afiliação
  • Seirafianpour F; Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Mozafarpoor S; Department of Dermatology, Skin Disease and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Fattahi N; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Sadeghzadeh-Bazargan A; Department of Dermatology, Rasoul Akram Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran.
  • Hanifiha M; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Goodarzi A; Children Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Dermatol Ther ; 33(4): e13733, 2020 Jul.
Article em En | MEDLINE | ID: mdl-32473070
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pentoxifilina / Inibidores de Fosfodiesterase / Pneumonia Viral / Infecções por Coronavirus Limite: Humans Idioma: En Revista: Dermatol Ther Assunto da revista: DERMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Irã
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pentoxifilina / Inibidores de Fosfodiesterase / Pneumonia Viral / Infecções por Coronavirus Limite: Humans Idioma: En Revista: Dermatol Ther Assunto da revista: DERMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Irã